Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Dec 22 2025

Full Issue

HPV Vaccines Prevent Much More Than Cervical Cancer, Study Finds

The research, published in JAMA Oncology, found that the rate of precancerous vulvar or vaginal lesions was 37% lower in those who'd gotten at least one dose of HPV vaccine. Also: proton beam radiation therapy, mpox, and more.

CIDRAP: HPV Vaccines Prevent Precancerous Lesions In Vulva And Vagina, Study Finds

Although human papillomavirus (HPV) vaccines are best known for preventing cervical cancer, a new study from Sweden finds that women and girls who received the immunizations are also less likely to develop precancerous lesions of the vulva and vagina. The rate of precancerous vulvar or vaginal lesions was 37% lower in women and girls who received at least one dose of HPV vaccine than among study participants who did not, according to a study from Sweden’s Karolinska Institute published yesterday in JAMA Oncology. (Szabo, 12/19)

The Baltimore Sun: Research Shows Proton Beam Therapy Improves Cancer Survival, Lowers Side Effects

Proton beam radiation therapy performed 10% better at stopping cancer of the throat compared to traditional X-ray radiation, a new study shows, with 15% fewer side effects. (Hille, 12/19)

Stat: Unpopular Diet For Cancer Patients Gets Another Look 

Oncologists have been moving away from the notoriously unpopular neutropenic diet. It requires nearly all food to be cooked to high temperatures — or, as some have described it, “boiled to death” — to reduce the risk of food-borne illnesses. But since evidence in recent years suggested the diet didn’t actually help ward off infections, doctors started leaning away from a strict neutropenic diet. (Chen, 12/22)

AP: US Military To Stop Shooting Goats And Pigs For Training

The U.S. military will stop its practice of shooting pigs and goats to help prepare medics for treating wounded troops in a combat zone, ending an exercise made obsolete by simulators that mimic battlefield injuries. The prohibition on “live fire” training that includes animals is part of this year’s annual defense bill, although other uses of animals for wartime training will continue The ban was championed by Rep. Vern Buchanan, a Florida Republican who often focuses on animal rights issues. (Finley, 12/19)

CIDRAP: Reports Show How Mpox Clade 1b Spreads Through Non-Sexual Contact In DR Congo, Ireland

In a study published yesterday in Eurosurveillance, a team led by Johns Hopkins University researchers describe an mpox clade 1b outbreak in Uvira, a densely populated city in the Democratic Republic of the Congo (DRC), where transmission was driven primarily by household contact rather than sexual exposure. A second report in the same journal details sexual, household, and health care spread of clade 1b in Ireland’s first documented outbreak. (Bergeson, 12/19)

CIDRAP: Experimental Multistage Malaria Vaccine Shows Promising Protection In Small Trial 

A multistage malaria vaccine showed encouraging levels of protection against controlled human malaria infection (CHMI) in Malian adults with lifelong exposure to the causative parasite, according to a new phase 2 randomized controlled trial published in The Lancet Infectious Diseases. The investigational vaccine, ProC6C-AlOH/Matrix-M, targets multiple stages in the life cycle of Plasmodium falciparum, a protozoan that causes the most severe form of malaria in people. (Bergeson, 12/19)

Also —

CNN: Does Science Agree It’s Better To Give Than Receive? A Doctor Explains

The holidays are here, which means you’re probably thinking about gifts — what to buy, whom to give to and how much to spend. Gift-giving is often framed as a source of stress and obligation, but a growing body of research suggests there may also be something beneficial about giving itself. (Hetter, 12/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF